Signs of biological activity observed in peripheral blood did not translate into meaningful changes in the tumor microenvironment, and the low clinical activity indicates that resistance to PD-1 CPI cannot be overcome by the addition of FAP-IL2v. Here, FAP is linked to neoplasm.